International Finance and Accounting Handbook

22 • 18

KEY DATA BY SEGMENT (2)Segments

Reconciliation

Continuing Operations

Discontinuing Operations

Bayer Group

Euros in millions—2001Net sales (external)

872

28,938

1,337

30,275

• Change in euros

+1.1%

–2.2%

• Change in local currencies

+0.8%

–2.5%

Intersegment sales

(857)

Other operating income

63

480

340

820

Operating result before exceptionals

(246)

1,855

76

1,931

Return on sales before exceptionals

6.4%

6.4%

Exceptional items

(16)

(613)

293

(320)

Operating result

(262)

1,242

369

1,611

Return on sales

4.3%

5.3%

Gross cash flow

(230)

2,826

97

2,923

Capital invested

556

33,466

1,392

34,858

CFROI

8.3%

8.2%

Equity-method income

12

12

14

26

Equity-method investments

158

987

179

1,166

Total assets

4,933

35,990

1,049

37,039

Capital expenditures

40

2,553

64

2,617

Amortization and depreciation

41

2,403

113

2,516

Liabilities

9,616

19,712

307

20,019

Research and development expenses

170

2,488

71

2,559

Number of employees (as of Dec. 31)

3,000

112,000

4,900

116,900

Exhibit 22.4.

(Continued

)